Filters
Advising Zeelo on its US$23 million Series B funding
Advising on Draig Therapeutics' US$140 million series A financing
Work/Life - international employment news update
Consumer and Retail in the News
Our survey says … Building cyber resilience in the financial sector
Fashion and Luxury Market Update
Does regulation kill innovation?
How can GCs support growth and ensure regulatory compliance?
UPC patent infringement: recent updates for the life sciences sector
The United Patent Court (UPC) is increasingly influential in life sciences patent disputes, especially for pharmaceuticals, biotech, and medical devices. Handling 26% of infringement cases in this sector, the UPC offers faster, pan-European enforcement and is clarifying key legal issues. It’s becoming a crucial venue for protecting evolving life sciences innovations across Europe.
3 of 5 Insights
The UPC going beyond its borders: how your company can profit from the latest case law
The UPC now allows life sciences companies to enforce European patents more efficiently across multiple countries through its long-arm jurisdiction. This lets patent holders sue distributors based in UPC member states in a single action, even if products are sold or made in non-UPC countries. Following key rulings the UPC can issue cross-border injunctions covering several national patent parts, while respecting jurisdiction limits on patent validity challenges.
5 of 5 Insights
